Intelligent Trials

Improve site selection even before you start your trial to meet enrollment timelines by leveraging industry-wide, real-time, and historical enrollment performance data, supported by predictive analytics and enrollment forecasting.

Learn more about Intelligent Trials Study Feasibility.

Ensure your trials reflect the diversity of real-world populations by selecting sites with a proven track record of recruiting diverse patients. Our indication-specific, cross-industry data allows you to identify and prioritize sites that consistently meet diversity goals, helping you achieve your inclusivity targets and drive equitable clinical outcomes.

Learn more about the Intelligent Trials Study Feasibility Diversity Module.

Identify opportunities to improve operational performance and accelerate enrollment by comparing your trial to the performance of industry trials and forecasting enrollment.

Learn more about Intelligent Trials Performance Analytics.

Medidata Selected by Worldwide Clinical Trials to Accelerate Trials and Transform Patient Experience

Medidata and Worldwide Clinical Trials have expanded their partnership to leverage Medidata’s advanced solutions and extensive data set, enhancing Worldwide’s clinical operations with data-driven insights to accelerate trial timelines, improve site selection, and advance the life sciences industry.

ASCO Education: Racial Disparities in Clinical Trial Participation

Learn about the state of clinical trial diversity in clinical trials and what clinicians and trial sponsors can do to improve participant diversity.

3 Ways to Approach Challenges During Study Feasibility Processes

Real-time, industry data and predictive models enable pharmaceutical companies and CROs to improve clinical trial site selection, forecast enrollment timelines, and optimize study feasibility through accurate scenario analysis and site performance predictions.